• EDEN has received a development permit for a new retail location in Vancouver
  • The company is partnering with an arm’s length third party to operate the location
  • EDEN intends to use proceeds from the partnership to expand its footprint in Michigan
  • EDEN is in the business of investments and operations in the cannabis sector and engaging in retail cannabis sales
  • Eden Empire Inc. (EDEN) opened trading at C$0.10 per share

The City of Vancouver has granted Eden Empire (EDEN) a development permit for a new retail cannabis location.

The retail store is located at 348 Water Street, in the heart of Gastown.

EDEN has also entered into a letter of intent with an arm’s length third party to operate its Gastown location as a joint venture for proceeds of C$500,000.

The company intends to use these funds to expand its footprint in the State of Michigan.

Gerry Trapasso, Director & CEO of EDEN, commented,

“Being located just footsteps from Terminal Station and the historic Gastown Steam Clock makes this location a massive attraction for tourists, visitors and residents of the area. We are extremely excited about the introduction to this area and feel our boutique-style culture provides an exciting opportunity in Gastown. Obtaining the Gastown location allows EDEN to uniquely position itself with key retail locations within the City of Vancouver.”

EDEN is in the business of investments and operations in the cannabis sector and engaging in retail cannabis sales. 

Upon completion of EDEN’s currently intended acquisitions, and approval to operate its retail locations, the company is expected to have a significant retail cannabis footprint in Canada and Michigan. Retail cannabis operations are an emerging sector with significant cash flow potential.

Eden Empire Inc. (EDEN) opened trading at C$0.10 per share.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.